Epidemiology


Leading cause of acute liver failure

Etiology


Pathophysiology


  • Exhaustion of hepatic metabolic pathways causes accumulation of a toxic metabolite of acetaminophen, N-acetyl-p-benzoquinoneimine (NAPQI).
    • Glutathione initially inactivates NAPQI, but its reserves are eventually depleted, leading to NAPQI accumulation.
    • NAPQI → irreversible oxidative hepatocyte injury → liver cell necrosis
  • APAP-induced hepatotoxicity
    • Defined as peak AST or ALT > 1000 IU/L
    • Most commonly caused by APAP overdose
    • Occurs rarely at therapeutic doses in patients with:
      • Alcohol consumption
      • Prolonged fasting
      • Chronic liver disease

Clinical features


  • Nausea, vomiting
  • Pallor
  • RUQ pain
  • Signs of acute liver failure

Diagnostics


Differential diagnostics


t

FeatureSalicylate (ASA)Acetaminophen (APAP)Reye Syndrome
PathUncouple oxidative phosphorylation (leads to hyperthermia); Direct stimulation of resp center.Glutathione depletion NAPQI centrilobular hepatic necrosis.Mito dysfunction ( -oxidation) Microvesicular fatty change in liver
Hx/TriggerOD; Wintergreen oilOD (esp. w/ CYP inducers/EtOH)Child + Virus + ASA
Key SxTinnitus, Hyperthermia, TachypneaRUQ pain, Fulminant liver failureEncephalopathy, Vomiting
Labs/PathMixed Resp Alk + Met AcidosisZone 3 Necrosis, AST/ALTMicrovesicular fatty liver, Glucose, Ammonia
TxNaHCO3 (Alkalinize urine), DialysisN-acetylcysteine (restore glutathione)Supportive

Treatment


  • Antidote: PO or IV N-acetylcysteine (NAC) is used to treat and prevent APAP-induced hepatoxicity.
    • NAC regenerates glutathione